These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 12704355

  • 1. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
    Wahn U, Meltzer EO, Finn AF, Kowalski ML, Decosta P, Hedlin G, Scheinmann P, Bachert C, Rosado Pinto JE, Baena-Cagnani C, Potter P, Simons FE, Ruuth E.
    J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
    Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J.
    J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO, Scheinmann P, Rosado Pinto JE, Bachert C, Hedlin G, Wahn U, Finn AF, Ruuth E.
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.
    Van Cauwenberge P, Juniper EF.
    Clin Exp Allergy; 2000 Jun; 30(6):891-9. PubMed ID: 10848909
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH, Briscoe MP, Rafeiro E, Ratz JD, Ellis AK, Frankish CW, Chapman D, deGuia EC, Kramer B, Warner C.
    Allergy Asthma Proc; 2005 Jun; 26(4):275-82. PubMed ID: 16270720
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF, Corren J, Wheeler WJ, Berger WE, Rhinitis Study Group.
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [Abstract] [Full Text] [Related]

  • 7. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G.
    Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
    [Abstract] [Full Text] [Related]

  • 8. The efficacy and safety of 30 mg fexofenadine HCl bid in pediatric patients with allergic rhinitis.
    Ngamphaiboon J, Direkwattanachai C, Visitsunthorn N, Vangveeravong M, Tiensuwan M.
    Asian Pac J Allergy Immunol; 2005 Dec; 23(4):169-74. PubMed ID: 16572735
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis.
    Bernstein DI, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason J.
    Ann Allergy Asthma Immunol; 1997 Nov; 79(5):443-8. PubMed ID: 9396979
    [Abstract] [Full Text] [Related]

  • 10. Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
    Berkowitz RB, McCafferty F, Lutz C, Bazelmans D, Godfrey P, Meeves S, Liao Y, Georges G.
    Allergy Asthma Proc; 2004 Nov; 25(5):335-43. PubMed ID: 15603207
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
    Sussman GL, Mason J, Compton D, Stewart J, Ricard N.
    J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis.
    Casale TB, Andrade C, Qu R.
    Allergy Asthma Proc; 1999 Jul; 20(3):193-8. PubMed ID: 10389553
    [Abstract] [Full Text] [Related]

  • 13. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
    Meltzer EO, Casale TB, Nathan RA, Thompson AK.
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):311-7. PubMed ID: 10541423
    [Abstract] [Full Text] [Related]

  • 14. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH, Briscoe MP, Rafeiro E, Hewlett D, Chapman D, Kramer B.
    Allergy Asthma Proc; 2004 Oct; 25(1):59-68. PubMed ID: 15055564
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of desloratadine, 5 mg, compared with fexofenadine, 180 mg, in patients with symptomatic seasonal allergic rhinitis.
    Berger WE, Lumry WR, Meltzer EO, Pearlman DS.
    Allergy Asthma Proc; 2006 Oct; 27(3):214-23. PubMed ID: 16913264
    [Abstract] [Full Text] [Related]

  • 16. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.
    Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE.
    Int Arch Allergy Immunol; 2011 Oct; 156(1):1-15. PubMed ID: 21969990
    [Abstract] [Full Text] [Related]

  • 17. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
    Simpson K, Jarvis B.
    Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.
    Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):73-9. PubMed ID: 14756468
    [Abstract] [Full Text] [Related]

  • 19. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
    Berkowitz RB, Woodworth GG, Lutz C, Weiler K, Weiler J, Moss M, Meeves S.
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
    [Abstract] [Full Text] [Related]

  • 20. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C.
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.